Citigroup’s Sharps Compliance Corp SMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-181
Closed -$1K 6652
2022
Q2
$1K Sell
181
-765
-81% -$3.19K ﹤0.01% 6173
2022
Q1
$6K Sell
946
-4,598
-83% -$28.9K ﹤0.01% 5790
2021
Q4
$40K Buy
5,544
+3,858
+229% +$29.6K ﹤0.01% 5182
2021
Q3
$14K Sell
1,686
-152
-8% -$1.41K ﹤0.01% 5393
2021
Q2
$19K Sell
1,838
-261
-12% -$3.63K ﹤0.01% 5348
2021
Q1
$30K Sell
2,099
-1,719
-45% -$22.1K ﹤0.01% 5017
2020
Q4
$36K Buy
3,818
+35
+0.9% +$268 ﹤0.01% 6275
2020
Q3
$24K Sell
3,783
-61
-2% -$444 ﹤0.01% 6072
2020
Q2
$27K Buy
3,844
+1,900
+98% +$13.5K ﹤0.01% 6396
2020
Q1
$15K Hold
1,944
﹤0.01% 6867
2019
Q4
$8K Hold
1,944
﹤0.01% 7289
2019
Q3
$8K Hold
1,944
﹤0.01% 7191
2019
Q2
$7K Hold
1,944
﹤0.01% 7415
2019
Q1
$7K Hold
1,944
﹤0.01% 7358
2018
Q4
$6K Hold
1,944
﹤0.01% 7324
2018
Q3
$7K Buy
+1,944
New +$6.84K ﹤0.01% 7450
2015
Q4
Sell
-394
Closed -$3K 7971
2015
Q3
$3K Buy
394
+392
+19,600% +$2.83K ﹤0.01% 6955
2015
Q2
$0 Sell
2
-1
-33% -$6 ﹤0.01% 7843
2015
Q1
$0 Buy
+3
New +$15 ﹤0.01% 7520

Citigroup's SMED Position: Q3 2022 in Review

Citigroup sold out of Sharps Compliance Corp (SMED) in Q3 2022, closing a stake of 181 shares — an estimated $1K sold.

Citigroup first reported a position in SMED in Q1 2015 and held it in 19 quarters. The position peaked at $40K in Q4 2021. 0 funds tracked by Wall St. Rank hold SMED as of Q3 2022.

  • Citigroup reported no remaining Sharps Compliance Corp position as of Q3 2022 after selling out during the quarter.
  • Citigroup sold 181 Sharps Compliance Corp shares in Q3 2022, an estimated $1K.
  • Citigroup first reported a position in Sharps Compliance Corp in Q1 2015 and held it in 19 quarters.
  • Citigroup's Sharps Compliance Corp position peaked at $40K in Q4 2021.
  • 0 funds tracked by Wall St. Rank held Sharps Compliance Corp as of Q3 2022.

Based on Citigroup's 13F filing for Q3 2022, filed 10 Nov 2022.